TerrAscend

About

TerrAscend is a Canadian cannabis company engaged in providing products, brands, and services to the cannabinoid market.

Mississauga,Ontario,Canada
https://www.terrascend.com/

Highlights

Details

Last Funding Type: Post-IPO Debt
Last Funding Money Raised: $55M
Industries: Cannabis,Clinical Trials,Health Care,Medical,Pharmaceutical
Founded date: Jan 1, 2017
Operating Status: Active
Stock Symbol: cnsx:TER
Legal Name: TerrAscend Corporation

TerrAscend is a vertically-integrated Canadian cannabis company that strives to create and deliver quality products and services that meet the evolving needs of the cannabis market. It provides support to patients through its wholly-owned subsidiaries, Solace Health Inc., a licensed producer of cannabis under the Access to Cannabis for Medical Purposes Regulations, and Terra Health Network Inc., a provider of clinical support and education programs led by health care professionals.

TerrAscend offers prescription cannabinoids and medical cannabis solutions for patients suffering from chronic pain and debilitating illnesses and focuses on drug research and development, cannabis devices, delivery systems, and hemp health products.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

10

$349.15M $69M

TerrAscend has raised a total of $349.15M $69M in funding over 2 rounds. Their latest funding was raised on Nov 30, 2022 from a Post-IPO Debt round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 30, 2022	Post-IPO Debt	$55M	—	—	—	Detail
Oct 12, 2022	Post-IPO Debt	$45.50M	1	Pelorus Equity Group	—	Detail
Dec 18, 2020	Post-IPO Debt	$120M	—	—	—	Detail
May 25, 2020	Post-IPO Equity	$30M	—	—	—	Detail
Jan 13, 2020	Post-IPO Equity	$33.50M	—	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

5

0

TerrAscend has made 5 investments. Their most recent investment was on Apr 6, 2022, when Binance.US raised $200M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Apr 6, 2022 Binance.US	Seed	$200M	Cryptocurrency	—
Mar 11, 2020 Canopy Growth	Post-IPO Debt	$58.80M	Cannabis	—
Sep 24, 2019 Stacks	Initial Coin Offering	$23M	Apps	—
May 24, 2016 BitOasis	Seed	—	Bitcoin	—
Feb 2, 2016 FiscalNote	Series C	$10M	Artificial Intelligence	—

Investors

Number of Lead Investors

Number of Investors

3

4

TerrAscend is funded by 4 investors. Pelorus Equity Group and RIV Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
Pelorus Equity Group	Yes	Post-IPO Debt
RIV Capital	Yes	Post-IPO Equity
JW Asset Management	Yes	Post-IPO Equity
Canopy Growth	—	Post-IPO Equity

Employee Profiles

Number of Employee Profiles

5

TerrAscend has 5 current employee profiles, including Board member Jason Wild

Board member

Executive

Executive

Executive

Executive

Exits

TerrAscend has had 1 exits. TerrAscend most notable exits include Canopy Growth

Date	Company Name	Exit Type	Industry
Jul 27, 2016	Canopy Growth	IPO	Cannabis	Detail

Acquisition

TerrAscend has acquired 7 organizations. Their most recent acquisition was The Apothecarium on Feb 12, 2019. They acquired The Apothecarium for $118.40M.

Date Company Name	Industry	Acquisition Type	Price
Feb 12, 2019 The Apothecarium	Cannabis	acquisition	$ 118.40M	Detail
Aug 2, 2019 Ilera Healthcare	Alternative Medicine	acquisition	—	Detail
May 3, 2021 Keystone Canna Remedies	Cannabis	acquisition	$ 70M	Detail
May 4, 2021 HMS Health	Cannabis	acquisition	$ 27.50M	Detail
Sep 1, 2021 Gage Cannabis	Cannabis	acquisition	$ 545M	Detail